Pantoprazole Azevedos (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Erosive esophagitis: promotes mucosal healing and symptom relief.
• Prevention of NSAID‑induced ulcer complications: reduces the risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, allowing the gastrointestinal mucosa to heal and symptoms to improve.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation.
• Liver enzyme elevation: signs of hepatitis.

When prescribing Pantoprazole, consider the following precautions:

• Assess renal function: adjust use in severe impairment.
• Evaluate hepatic function: use with caution in severe liver disease.
• Review long‑term use: monitor for bone density loss.
• Monitor electrolytes: watch for hypomagnesemia during extended therapy.
• Pregnancy and lactation: weigh benefits against potential risks.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid)

• Ketoconazole: reduced absorption leading to therapeutic failure.
• Atazanavir: decreased plasma concentrations and loss of antiviral effect.
• Clopidogrel: diminished antiplatelet activity, increasing clot risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR values.
• Digoxin: possible increase in serum levels.
• Methotrexate: reduced clearance may raise toxicity risk.